229 related articles for article (PubMed ID: 15451221)
1. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
[TBL] [Abstract][Full Text] [Related]
2. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the design of antibiotic equivalency studies: the multicenter equivalency study of oral amoxicillin versus injectable penicillin in children aged 3-59 months with severe pneumonia.
Hibberd PL; Patel A;
Clin Infect Dis; 2004 Aug; 39(4):526-31. PubMed ID: 15356816
[TBL] [Abstract][Full Text] [Related]
4. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.
Bansal A; Singhi SC; Jayashree M
Indian J Pediatr; 2006 Apr; 73(4):305-9. PubMed ID: 16816491
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
[TBL] [Abstract][Full Text] [Related]
6. Oral antibiotics for the treatment of severe pneumonia in children.
Klugman KP; Madhi SA
Lancet; 2004 Sep 25-Oct 1; 364(9440):1104-5. PubMed ID: 15451204
[No Abstract] [Full Text] [Related]
7. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
[TBL] [Abstract][Full Text] [Related]
8. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
10. Brief hospitalization and pulse oximetry for predicting amoxicillin treatment failure in children with severe pneumonia.
Fu LY; Ruthazer R; Wilson I; Patel A; Fox LM; Tuan TA; Jeena P; Chisaka N; Hassan M; Lozano J; Maulen-Radovan I; Thea DM; Qazi S; Hibberd P
Pediatrics; 2006 Dec; 118(6):e1822-30. PubMed ID: 17142503
[TBL] [Abstract][Full Text] [Related]
11. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of injectable penicillin versus a combination of penicillin and gentamicin in children with pneumonia characterised by indrawing in Kenya: a retrospective observational study.
Malla L; Perera-Salazar R; McFadden E; English M
BMJ Open; 2017 Nov; 7(11):e019478. PubMed ID: 29146662
[TBL] [Abstract][Full Text] [Related]
13. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.
Agarwal G; Awasthi S; Kabra SK; Kaul A; Singhi S; Walter SD;
BMJ; 2004 Apr; 328(7443):791. PubMed ID: 15070633
[TBL] [Abstract][Full Text] [Related]
14. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Asghar R; Banajeh S; Egas J; Hibberd P; Iqbal I; Katep-Bwalya M; Kundi Z; Law P; MacLeod W; Maulen-Radovan I; Mino G; Saha S; Sempertegui F; Simon J; Santosham M; Singhi S; Thea DM; Qazi S;
BMJ; 2008 Jan; 336(7635):80-4. PubMed ID: 18182412
[TBL] [Abstract][Full Text] [Related]
15. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia.
Tsarouhas N; Shaw KN; Hodinka RL; Bell LM
Pediatr Emerg Care; 1998 Oct; 14(5):338-41. PubMed ID: 9814400
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Amir J; Harel L; Eidlitz-Markus T; Varsano I
Clin Pediatr (Phila); 1996 Dec; 35(12):629-33. PubMed ID: 8970755
[TBL] [Abstract][Full Text] [Related]
18. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
Trémolières F; de Kock F; Pluck N; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):447-53. PubMed ID: 9758291
[TBL] [Abstract][Full Text] [Related]
19. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Oh HM; Ng AW; Lee SK
Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
[TBL] [Abstract][Full Text] [Related]
20. Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia.
Cardoso MR; Nascimento-Carvalho CM; Ferrero F; Berezin EN; Ruvinsky R; Camargos PA; Sant'anna CC; Brandileone MC; de Fátima P March M; Feris-Iglesias J; Maggi RS; Benguigui Y;
Arch Dis Child; 2008 Mar; 93(3):221-5. PubMed ID: 17848490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
